Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafei Chai

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Pharmacological Research|December 16, 2021
Adenovirus vaccine therapy with CD137L promotes CD8<sup>+</sup> DCs-mediated multifunctional CD8<sup>+</sup> T cell immunity and elicits potent anti-tumor activityJiage Ding, Nan Jiang, Yanyan Zheng, et al.
Molecular Cancer|January 13, 2025
Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunityDafei Chai, Junhao Wang, Jing Ming Lim, et al.
Cancer Science|June 22, 2021
Co-immunization with L-Myc enhances CD8<sup>+</sup> or CD103<sup>+</sup> DCs mediated tumor-specific multi-functional CD8<sup>+</sup> T cell responsesDafei Chai, Zichun Zhang, Nan Jiang, et al.
Molecular Immunology|September 24, 2021
Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinomaHuanyou Sun, Juan Li, Wenwen Hu, et al.
Drug Delivery|March 4, 2022
Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug deliveryYuxin Chen, Lulu Han, Xiaoyan Qiu, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumorsFei Zhu, Zheng Lu, Wenjing Tang, et al.
Cancers|September 23, 2022
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8<sup>+</sup> T Cell Anti-Tumor Immunity in Hepatocellular CarcinomaYanyan Zheng, Zheng Lu, Jiage Ding, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
VISTA neutralization by immunization reprograms immunosuppression and augments vaccine efficacy in renal carcinomaJiawei Wang, Zhenzhen Wang, Wanting Zhao, et al.
Cell Death Discovery|September 2, 2023
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumorsLin Fang, Sen Yuan, Meng Wang, et al.
BJC Reports|February 5, 2024
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancerNavid Sobhani, Dana Rae Tardiel-Cyril, Dafei Chai, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Pharmacological Research|December 16, 2021
Adenovirus vaccine therapy with CD137L promotes CD8<sup>+</sup> DCs-mediated multifunctional CD8<sup>+</sup> T cell immunity and elicits potent anti-tumor activityJiage Ding, Nan Jiang, Yanyan Zheng, et al.
Molecular Cancer|January 13, 2025
Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunityDafei Chai, Junhao Wang, Jing Ming Lim, et al.
Cancer Science|June 22, 2021
Co-immunization with L-Myc enhances CD8<sup>+</sup> or CD103<sup>+</sup> DCs mediated tumor-specific multi-functional CD8<sup>+</sup> T cell responsesDafei Chai, Zichun Zhang, Nan Jiang, et al.
Molecular Immunology|September 24, 2021
Co-immunizing with HMGB1 enhances anti-tumor immunity of B7H3 vaccine in renal carcinomaHuanyou Sun, Juan Li, Wenwen Hu, et al.
Drug Delivery|March 4, 2022
Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug deliveryYuxin Chen, Lulu Han, Xiaoyan Qiu, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumorsFei Zhu, Zheng Lu, Wenjing Tang, et al.
Cancers|September 23, 2022
Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8<sup>+</sup> T Cell Anti-Tumor Immunity in Hepatocellular CarcinomaYanyan Zheng, Zheng Lu, Jiage Ding, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
VISTA neutralization by immunization reprograms immunosuppression and augments vaccine efficacy in renal carcinomaJiawei Wang, Zhenzhen Wang, Wanting Zhao, et al.
Cell Death Discovery|September 2, 2023
Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumorsLin Fang, Sen Yuan, Meng Wang, et al.
BJC Reports|February 5, 2024
Artificial intelligence-powered discovery of small molecules inhibiting CTLA-4 in cancerNavid Sobhani, Dana Rae Tardiel-Cyril, Dafei Chai, et al.
Pageof 6